Results 191 to 200 of about 70,411 (245)
Adjuvant chemoradiotherapy with procarbazine, lomustine, and vincristine (PCV) or temozolomide for 1p/19q Co-deleted anaplastic oligodendroglioma: a systematic review and network meta-analysis. [PDF]
Santos MDC +13 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Critical Reviews in Oncology/Hematology, 1999
Item does not contain ...
Gidding, C.E.M. +3 more
openaire +3 more sources
Item does not contain ...
Gidding, C.E.M. +3 more
openaire +3 more sources
The Journal of Pediatrics, 1976
Five patients received overdoses of vincristine ranging from 3.5 to 32 mg. Neurotoxicity accounted for most of the complications observed. Peripheral neuropathies, cranial nerve palsies, paralytic ileus, atony of the bladder, hypertension, hypotension, seizures, inappropriate ADH secretion, and severe bone marrow depression were all encountered.
I A, Kaufman +3 more
openaire +2 more sources
Five patients received overdoses of vincristine ranging from 3.5 to 32 mg. Neurotoxicity accounted for most of the complications observed. Peripheral neuropathies, cranial nerve palsies, paralytic ileus, atony of the bladder, hypertension, hypotension, seizures, inappropriate ADH secretion, and severe bone marrow depression were all encountered.
I A, Kaufman +3 more
openaire +2 more sources
Pediatrics, 1980
Vincristine is an effective and potent antileukemic agent. Its FDA-approved labeling, ie, its package insert, does not contain directions for treatment of overdose. Several recent communications1-7 report accidental overdoses whose outcome was often fatal (Table).
openaire +2 more sources
Vincristine is an effective and potent antileukemic agent. Its FDA-approved labeling, ie, its package insert, does not contain directions for treatment of overdose. Several recent communications1-7 report accidental overdoses whose outcome was often fatal (Table).
openaire +2 more sources
Cardiovascular Toxicity Induced by Chronic Vincristine Treatment
Frontiers in Pharmacology, 2021Visitacion Lopez-Miranda
exaly

